You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 13, 2025

Details for Patent: 8,071,613


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,071,613
Title:Anti-constipation composition
Abstract: An object of the present invention is to provide an anti-constipation composition containing a halogenated-bi-cyclic compound as an active ingredient in a ratio of bi-cyclic/mono-cyclic structure of at least 1:1. The halogenated-bi-cyclic compound is represented by Formula (I): ##STR00001## where X.sub.1 and X.sub.2 are preferably both fluorine atoms. The composition can be used to treat constipation without substantive side-effects, such as stomachache.
Inventor(s): Ueno; Ryuji (Potomac, MD)
Assignee: Sucampo AG (Zurich, CH)
Application Number:11/142,251
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,071,613
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

United States Patent 8,071,613: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

The United States Patent 8,071,613, titled "Anti-constipation composition," is a patent that has garnered attention for its innovative approach to treating constipation. This article will delve into the scope, claims, and the broader patent landscape surrounding this patent.

Patent Overview

Title and Abstract

The patent, filed on June 2, 2005, and granted on December 6, 2011, describes an anti-constipation composition containing a halogenated bi-cyclic compound as the active ingredient. The invention aims to provide an effective treatment for constipation using a novel therapeutic composition[4].

Scope of the Patent

Claims

The patent includes multiple claims that define the scope of the invention. Here are some key claims:

  • Independent Claims: These claims define the broadest scope of the invention. For example, Claim 1 might describe the anti-constipation composition comprising a halogenated bi-cyclic compound, while subsequent claims might narrow down the scope by specifying particular compounds, formulations, or methods of use.
  • Dependent Claims: These claims build upon the independent claims and provide additional details or limitations. For instance, a dependent claim might specify a particular dosage form or a method of administration[4].

Claim Language and Scope

The scope of the patent is heavily influenced by the language used in the claims. Research has shown that the length and count of independent claims can be significant metrics for measuring patent scope. Patents with narrower claims at publication tend to have a higher probability of grant and a shorter examination process[3].

Patent Claims Analysis

Independent Claim Length and Count

  • The length of independent claims can indicate the complexity and breadth of the invention. Shorter claims often suggest a more focused invention, while longer claims may indicate a broader scope.
  • The count of independent claims also matters; fewer independent claims generally suggest a narrower scope, while multiple independent claims can indicate a broader or more complex invention[3].

Claim Construction

The construction of claims is crucial in defining the patent's scope. Claims must be clear and definite to avoid ambiguity and potential litigation. In the case of US 8,071,613, the claims would need to clearly define what constitutes the halogenated bi-cyclic compound and its use in treating constipation.

Patent Landscape

Prior Art and Novelty

The patent landscape includes prior art that was considered during the examination process. The prior art keywords listed for US 8,071,613 include terms like "cyclic," "mono," "triglyceride," and "ratio," indicating the areas of existing knowledge that the patent sought to improve upon or differentiate from[4].

Forward Citations

Forward citations, which are citations to the patent by later patents, can indicate the impact and relevance of the invention. A higher number of forward citations often suggests that the patent is influential in its field.

Patent Maintenance Payments

The maintenance payments for a patent can also reflect its scope and importance. Patents with broader claims may require higher maintenance payments to keep them in force, as they cover a wider range of applications[3].

Examination Process

Narrowing of Claims

During the examination process, patent claims often undergo revisions to narrow their scope. This is done to ensure that the claims are valid and do not infringe on existing patents. The examination process for US 8,071,613 would have involved such revisions, potentially narrowing the claims to ensure they were granted[3].

Legal Status

As of the current date, the patent US 8,071,613 has expired due to fee-related issues. This means that the exclusive rights granted by the patent are no longer in effect, and the invention is now in the public domain[4].

Impact on the Market

Innovation and Competition

The expiration of the patent can have significant implications for the market. It allows other companies to develop similar products without infringing on the original patent, potentially increasing competition and driving innovation in the field of constipation treatments.

Regulatory and Licensing Considerations

Infringement Claims

For patents that are still in force, infringement claims are a critical aspect of patent law. The process for filing an administrative claim for patent infringement, as outlined in the Department of Defense regulations, involves detailed documentation and identification of the alleged infringing item or process[2].

Licensing and Assignments

Licensing and assignments are also important considerations. The Department of Defense has specific policies and procedures for handling licenses, assignments, and infringement claims related to patented inventions[2].

Public Access and Search Facilities

USPTO Public Search Facility

The United States Patent and Trademark Office (USPTO) provides public access to patent information through various facilities, including the Public Search Facility in Alexandria, VA. This allows researchers and the public to access and review patent documents, including those related to US 8,071,613[1].

Global Dossier

The Global Dossier service offered by the USPTO allows users to access file histories of related applications from participating IP Offices. This can be useful for understanding the global patent landscape and the family of patents related to US 8,071,613[1].

Key Takeaways

  • Patent Scope: The scope of US 8,071,613 is defined by its claims, which specify the use of halogenated bi-cyclic compounds for treating constipation.
  • Claims Analysis: The length and count of independent claims are crucial in determining the patent's scope and its likelihood of being granted.
  • Patent Landscape: The patent's impact is reflected in its forward citations, maintenance payments, and its position within the broader patent landscape.
  • Legal Status: The patent has expired due to fee-related issues, making the invention public domain.
  • Market Impact: The expiration of the patent can increase competition and drive innovation in constipation treatments.

FAQs

What is the main invention described in US 8,071,613?

The main invention described in US 8,071,613 is an anti-constipation composition containing a halogenated bi-cyclic compound as the active ingredient.

Why is the scope of a patent important?

The scope of a patent is important because it defines the exclusive rights granted to the patent holder. It determines what is protected and what is not, influencing the patent's validity and enforceability.

How does the examination process affect patent claims?

The examination process often results in the narrowing of patent claims to ensure they are valid and do not infringe on existing patents. This can involve revisions to the claim language and scope.

What happens when a patent expires?

When a patent expires, the exclusive rights granted by the patent cease, and the invention enters the public domain. This allows others to use, make, and sell the invention without infringing on the original patent.

How can one access information about US 8,071,613?

Information about US 8,071,613 can be accessed through the USPTO Public Search Facility or online databases such as Google Patents.

Cited Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Acquisition.gov - INFRINGEMENT CLAIMS, LICENSES, AND ASSIGNMENTS: https://www.acquisition.gov/dfars/subpart-227.70-infringement-claims-licenses-and-assignments
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Google Patents - US8071613B2 - Anti-constipation composition: https://patents.google.com/patent/US8071613B2/en

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,071,613

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,071,613

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1315485 ⤷  Subscribe C01315485/01 Switzerland ⤷  Subscribe
European Patent Office 1315485 ⤷  Subscribe C300757 Netherlands ⤷  Subscribe
European Patent Office 1315485 ⤷  Subscribe 49/2015 Austria ⤷  Subscribe
European Patent Office 1315485 ⤷  Subscribe 2015/028 Ireland ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.